Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−17.57USD
−8.24 MUSD
794.00 KUSD
14.03 M
About Gyre Therapeutics, Inc.
Sector
CEO
Han Ying
Headquarters
San Diego
Website
Employees (FY)
7
Founded
1997
FIGI
BBG000F88SY8
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GYRE is 15.02 USD — it has increased by 1.32% in the past 24 hours. Watch Gyre Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Gyre Therapeutics, Inc. stocks are traded under the ticker GYRE.
Gyre Therapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
GYRE stock is 2.13% volatile and has beta coefficient of −0.30. Track Gyre Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Gyre Therapeutics, Inc. there?
Yes, you can track Gyre Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
GYRE stock has fallen by 8.67% compared to the previous week, the month change is a 11.68% fall, over the last year Gyre Therapeutics, Inc. has showed a 355.23% increase.
GYRE net income for the last quarter is −1.58 M USD, while the quarter before that showed −2.47 M USD of net income which accounts for 36.25% change. Track more Gyre Therapeutics, Inc. financial stats to get the full picture.
Today Gyre Therapeutics, Inc. has the market capitalization of 1.27 B, it has decreased by 7.80% over the last week.
Like other stocks, GYRE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gyre Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GYRE reached its all-time high on Mar 1, 2011 with the price of 47927.89 USD, and its all-time low was 2.83 USD and was reached on Mar 20, 2023. View more price dynamics on GYRE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 7, 2024, the company has 7.00 employees. See our rating of the largest employees — is Gyre Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Gyre Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Gyre Therapeutics, Inc. stock shows the sell signal. See more of Gyre Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Gyre Therapeutics, Inc. EBITDA is −14.74 M USD, and current EBITDA margin is −3.67 K%. See more stats in Gyre Therapeutics, Inc. financial statements.